Investors

Copyright West LLC. Minimum 15 minutes delayed.

News Release

<< Back
Jun 7, 2012

OvaScience to Present at the Boston CEO Conference

CAMBRIDGE, Mass., Jun 07, 2012 -- OvaScience™, a fertility company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., chief executive officer of OvaScience, will present at the Boston CEO 2012 Conference on Monday, June 11 and Tuesday, June 12, 2012 at the Mandarin Oriental in Boston.

About OvaScience

 OvaScience is a fertility company focused on the discovery, development and commercialization of new treatments for infertility. OvaScience is working to improve the treatment of female infertility based on patented technology exclusively licensed from Massachusetts General Hospital. The company's team of scientists, physicians and advisers includes recognized leaders in the field of reproductive medicine.